The First New Schizophrenia Drug in Decades

Why Didn't the FDA Approve MDMA Therapy?

The First New Schizophrenia Drug in Decades …C0NTINUE READING HERE >>>

Key Takeaways
The FDA has approved Cobenfy, the first new schizophrenia treatment in over 30 years.Cobenfy helps reduce both positive and negative schizophrenia symptoms, with side effects compared to current medications.Clinical trials for Cobenfy showed no significant weight gain or treatment discontinuation, but long-term effectiveness remains uncertain due to short study durations.

The Food and Drug Administration (FDA) last week approved Bristol Myers Squibb’s antipsychotic drug, the first new treatment for schizophrenia in over three decades.

Current antipsychotic medications…

>

Be the first to comment

Leave a Reply

Your email address will not be published.


*